One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial
Study context
- Population
- Patients with chronic coronary syndromes undergoing coronary artery bypass graft (CABG)planned
- Participants
- 700 patients
- Planned comparison
- Ticagrelor + aspirin for 1 month vs placebo + aspirin after CABG
- Primary endpoint
- Hierarchical composite of:
- All-cause death
- Stroke
- MI
- Revascularisation
- Graft failure
- Follow-up
- 1 year
Methodological detailsrationale and design, double-blind, placebo-controlled, international, multicentre, prospective, Randomised 1:1
- Rationale and design
- Double-blind
- Placebo-controlled
- International
- Multicentre
- Prospective
- Randomised 1:1
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial. EuroIntervention. Published 4 March 2024. doi:10.
Summarised from the published abstract; every number is checked against it